NLRP3 and Obesity: Surprisingly, the myeloid cell-specific deletion of Sptlc-2 did not prevent HFD-induced adipose tissue inflammation and insulin resistance, suggesting its dispensable role in NLRP3 inflammasome activation in obesity [64].